Plain-English summary
Heartworm is transmitted by mosquitoes and can cause life-threatening disease in dogs. Prevention is far safer than treating an established infection — but which preventive, when to start, and how to test are clinical decisions. A 2026 paper in Parasites & Vectors reported a multicenter field trial of a novel chewable tablet (Credelio Quattro) aimed at preventing Dirofilaria immitis infection in dogs. PAWai surfaces studies like this so you arrive at the clinic with better questions, not so you can self-prescribe.
What this study is useful for
- Understanding that modern preventives are studied in formal field programs, not only lab models
- Reminding owners that “viral scare posts” are not a substitute for local veterinary guidance
- Prompting a conversation about testing cadence and travel/mosquito exposure
What this study is not
- Not dosing advice
- Not proof that one brand is right for every dog
- Not a reason to skip veterinary exams or antigen testing when your vet recommends them
What to track before your next vet visit
- Whether your dog is currently on a preventive (name, last dose date if known)
- Recent travel to higher-risk regions
- Any missed doses or gaps you remember
- Cough, exercise intolerance, or other respiratory/energy changes — mention them; do not self-diagnose heartworm from a post
What PAWai can help organize
PAWai can help you keep a dated note of preventives, travel, and symptoms so your vet gets a clearer timeline. PAWai does not diagnose heartworm disease and does not recommend or dispense medication.
Disclaimer
PAWai organizes information and educates pet owners. PAWai does not diagnose conditions or recommend treatment. Always consult a licensed veterinarian for medical decisions about your pet.
Citation
Young, L., et al. (2026). Efficacy of a novel chewable tablet (Credelio Quattro™) for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07379-0